Dr. Anjana Pillai explains, in an interview with CURE, that treatment for liver cancer depends heavily on stage, liver ...

Dr. Vinayak Venkataraman, medical oncologist and director of Sarcoma Pathways at Dana-Farber Cancer Institute in Boston, ...

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient ...

Compartmentalizing the diagnosis allowed her to continue working, using her professional life as a refuge during treatment.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

On Sept. 5, 2025, the U.S. Food and Drug Administration (FDA) approved Inlexzo (gemcitabine intravesical system) for adults ...

It wasn’t that I never expected a breast cancer diagnosis, it was that I had never even considered a breast cancer diagnosis.

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Keeping her hair helped Maureen Green feel like herself during treatment, as scalp cooling became a meaningful part of her ...

Introduction: October marks Breast Cancer Awareness Month, a chance to recognize survivors and support those currently in ...

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...